Johnson & Johnson (JNJ) operating KPIs
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)
Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%
Johnson & Johnson consumer Health depreciation and amortization ($M) [through FY2023Q2] ($M)
Form 10-Q / 10-K Segment Note
Latest, Q2 2023
100
Period ended Jul 2, 2023
Change on a year earlier
0.0%
100 in Q2 2022
History
26 quarters
Since Q1 2017
Sources
19
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Johnson & Johnson Consumer Health depreciation and amortization ($M) [through FY2023Q2] ($M), quarterly Q1 2017–Q2 2023 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/seg_da_ch_legacy
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.